================================
cada um interprete como quiser. De minha parte continuo odiando as empresas farmacêuticas cujo único objetivo é manter as pessoas vivas mas doentes e consumindo suas drogas; nunca cura-las.
a parte que me chamou atenção abaixo.
================================
"Around the same time, Mash was contacted by Howard Lotsof. They began working together and in 1995 secured full approval from the US Food and Drug Administration (FDA) to investigate its potential in humans.
But these tests cost millions of dollars, and Mash applied for five separate public grants but each one was declined.
Usually, this money would come from big pharmaceutical companies but drugs like ibogaine offer little potential for profit.
It only has to be taken once, unlike conventional treatments for heroin addiction such as methadone which is a substitute and addictive itself.
"One very cynical reason they are not being developed is that there is no patent on these drugs anymore so there is no pharmaceutical company involvement," says Ben Sessa."
Um comentário:
Primeiro: custei a perceber que onde se diz "fonte" é o link para o artigo.
Há poucos dias li, ou ouvi na TV, que são poucas as pesquisas de medicamentos para certas doenças raras porque, sendo raras as doenças, seriam poucos os potenciais "consumidores".
Postar um comentário